Sionna Therapeutics · 17 hours ago
Director, Clinical Development MD
Sionna Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel medicines for cystic fibrosis. The Director, Clinical Development will oversee clinical studies, contribute to development strategy, and ensure safety evaluation while collaborating with cross-functional teams.
BiotechnologyGeneticsHealth CareMedicalPharmaceuticalTherapeutics
Responsibilities
Serve as medical monitor for assigned clinical trials, providing ongoing medical oversight including review of safety data, eligibility assessments, medical queries, and protocol deviations
Collaborate with cross-functional study teams to support successful study execution, data integrity, and subject safety
Participate in the review and interpretation of clinical data, contributing to safety reviews, data listings review, and preparation of key study documents
Contribute to and/or serve as the lead for the development of clinical protocols, amendments, study designs, IBs, and other clinical and scientific documents
Assist in the development of clinical components of development plans in alignment with project strategy
Provide clinical expertise to internal stakeholders and external partners
Support safety oversight activities under the direction of the Senior Director
Review safety reports, SAEs, and aggregate data summaries; contribute to safety narratives and regulatory safety submissions
Participate in and/or serve as the lead in the preparation and review of regulatory documents including INDs/CTAs, briefing documents, and clinical sections of regulatory responses
Support preparation and delivery of internal and external clinical data presentations and publications
Adhere to GCP, ICH guidelines, and internal SOPs
Contribute input to clinical-related SOPs and quality processes as needed
Qualification
Required
MD or equivalent with 2–4 years of industry experience in a Clinical Development or medical monitoring role
5+ years of clinical practice experience; pulmonary or rare disease subspecialty highly desirable
Hands-on experience as a clinical trial medical monitor
Experience supporting or contributing to regulatory submissions
Strong working knowledge of GCP and ICH guidelines
Ability to work collaboratively across diverse teams
Excellent communication, analytical, and organizational skills
Willingness to travel a few times yearly to key events such as major medical conferences, investigator meetings
Company
Sionna Therapeutics
Sionna Therapeutics is developing novel small molecule therapies to treat cystic fibrosis (CF).
Funding
Current Stage
Public CompanyTotal Funding
$292MKey Investors
Enavate SciencesOrbiMed
2025-02-07IPO
2024-03-06Series C· $182M
2022-04-19Series B· $110M
Leadership Team
Recent News
MarketScreener
2025-12-22
MarketScreener
2025-11-28
BioTech Breakthrough
2025-11-08
Company data provided by crunchbase